Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans.

MLA

Capone, Stefania, et al. “Optimising T Cell (Re)Boosting Strategies for Adenoviral and Modified Vaccinia Ankara Vaccine Regimens in Humans.” NPJ Vaccines, vol. 5, Oct. 2020, p. 94. EBSCOhost, https://doi.org/10.1038/s41541-020-00240-0.

APA

Capone, S., Brown, A., Hartnell, F., Sorbo, M. D., Traboni, C., Vassilev, V., Colloca, S., Nicosia, A., Cortese, R., Folgori, A., Klenerman, P., Barnes, E., & Swadling, L. (2020). Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans. NPJ Vaccines, 5, 94. https://doi.org/10.1038/s41541-020-00240-0

Chicago

Capone, Stefania, Anthony Brown, Felicity Hartnell, Mariarosaria Del Sorbo, Cinzia Traboni, Ventzislav Vassilev, Stefano Colloca, et al. 2020. “Optimising T Cell (Re)Boosting Strategies for Adenoviral and Modified Vaccinia Ankara Vaccine Regimens in Humans.” NPJ Vaccines 5 (October): 94. doi:10.1038/s41541-020-00240-0.